estriol
AssetAlso called Blissel (estriol), Gelistrol (estriol), Ovestin, ITFE-2026
Activates estrogen receptors to restore vaginal epithelium and relieve symptoms of vulvar and vaginal atrophy.
- Stage
- Approved
- Modality
- Small molecule
- Target
- ESR2
- 2
- Indications
- 16
- Trials
- 4
- Developers
Indications
3No named disease
Approved, open.fda.gov, Jan 1, 2000
Vaginal atrophy
Phase 3, Completed, NCT04574999, clinicaltrials.gov, Oct 27, 2026
Atrophic vaginitis
Phase 1, Completed, NCT01370551, clinicaltrials.gov, Oct 27, 2026
In the full profile
- Target and mechanism3
- Owner and partners4
- Trials16
- Evidence for its targets4
- Competitors5
- Aging relevance1
- Signals14
Every asset’s record: target, stage, trials and the evidence behind it.